Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Monepantel by Neurizon Therapeutics for Motor Neuron Diseases: Likelihood of Approval
Monepantel is under clinical development by Neurizon Therapeutics and currently in Phase II for Motor Neuron Diseases. According to GlobalData,...
Data Insights
Monepantel by Neurizon Therapeutics for Amyotrophic Lateral Sclerosis: Likelihood of Approval
Monepantel is under clinical development by Neurizon Therapeutics and currently in Phase II for Amyotrophic Lateral Sclerosis. According to GlobalData,...